TSRMedics™ JOURNALclub - section headerWatch
Welcome to TSRMedics™ JOURNALclub
TSRMedics™JOURNALclubn is the section for discussion of published / yet-to-be-published medical journal articles that may be of interest to medics / potential medics.
Things that JOURNALclub cover
- different medical specialties
- nursing and its specialisation
- different therapy specialties
What JOURNALclub is not
- to discuss basic medica training pathway (covered by TSRMedics™BASICS)
- to discuss medical or health topics (covered by TSRMedics™TOPICS)
- to discuss medical philosophy / medical debate issues / medicine and society / medical news / medical history topics (covered by TSRMedics™D&CA)
- to discuss medicine and entertainement (covered by TSRMedics™ENTERTAINMENT)
(more sections to come)
What TSRMedics™ in general is not:
- a place to ask a doctor / nurse questions (there is a Health section on TSR - but it's for discussion of Health issues NOT diagnosis)
- a place to ask Medical / Dental / Nursing etc. admission questions (there are sections for those things on TSR)
1 Deep brain stimulation: practical insights and common queries
2 more common soon
Please post below if you'd like to contribute or if you have any suggestions of journals!
If my son’s research gets published I will be uploading it onto tsr as well
read an interesting excerpt from the journal of the american heart association regarding statin and antihypertensive use and obesity. Based on their findings, patients initiating these meds are 82% likely to develop obesity, with an 8% likelihood of increased inactivity. Whilst I do get the increased inactivity, the obesity thing is perplexing, particularlly with statins as their whole game is to, y'know' reduce LDLc (maybe there is some unanticipated effect of theirs whereby they case increase fat in adipose tissues in addition to reducing LDL via their effect on HMG-COAr).
whilst there are some drawbacks with the study (it was conducted on a population of 42000 Caucasian Finnish patients, it doesnt specify the morbidites which are being treated and it excluded T2DM patients + patients who didnt continue taking their medication within a year - also doesnt specify the conditions), it does pose some interesting questions which imo should be followed up (what is the affect on larger populations, the effect on BAME communities, effect on patients with different comobidities, breaking down obesity incidence based on drugs / drug classes and different conditions).
reality is, we know these drugs are helpful and are prescribed for a reason but it does also pose the question of considering alternate medication and seeing what treatments are on the horizon.